ANOR Anormed Ord (MM)

0.00

0.00 (0.00%)

Last Updated: -

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Anormed Ord (MM)	NASDAQ:ANOR	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%							0	-

Atticus Capital LP Opposes Genzyme bid for AnorMED

12/09/2006 6:57pm

PR Newswire (US)

Anormed Ord (MM) (NASDAQ:ANOR)
Historical Stock Chart

From Mar 2020 to Mar 2025

Click Here for more Anormed Ord (MM) Charts.

NEW YORK, Sept. 12 /PRNewswire/ -- Atticus Capital LP does not support Genzyme Corporation's (GENZ) bid for AnorMED Inc. (ANOR), believing that it is not in the best interest of shareholders. "We think the Genzyme bid undervalues the company, and support the efforts of AnorMED and its advisors to seek better alternatives," stated an Atticus spokesman. Atticus Capital currently owns 9.1% of the outstanding shares of AnorMED. DATASOURCE: Atticus Capital LP CONTACT: Robert Coburn of Atticus Capital LP, +1-212-373-0800